Cargando…

MR imaging in ovarian cancer

Magnetic resonance (MR) imaging is increasingly being used in patients with gynaecological disorders due to its high contrast resolution compared to computed tomography (CT) and ultrasound. In women presenting with an adnexal mass, ultrasound remains the primary imaging modality in the detection and...

Descripción completa

Detalles Bibliográficos
Autores principales: Sohaib, S.A.A., Reznek, R.H.
Formato: Texto
Lenguaje:English
Publicado: e-Med 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2727977/
https://www.ncbi.nlm.nih.gov/pubmed/17921097
http://dx.doi.org/10.1102/1470-7330.2007.9046
_version_ 1782170718010605568
author Sohaib, S.A.A.
Reznek, R.H.
author_facet Sohaib, S.A.A.
Reznek, R.H.
author_sort Sohaib, S.A.A.
collection PubMed
description Magnetic resonance (MR) imaging is increasingly being used in patients with gynaecological disorders due to its high contrast resolution compared to computed tomography (CT) and ultrasound. In women presenting with an adnexal mass, ultrasound remains the primary imaging modality in the detection and characterisation of such lesions. However, in recent years overwhelming evidence has accumulated for the use of MR imaging in patients with indeterminate adnexal masses particularly in younger women and where disease markers are unhelpful. In staging ovarian cancer and for evaluating therapeutic response MR imaging is as accurate as CT but CT remains the imaging modality of choice because it is more widely available and quicker. This article reviews that evidence and outlines a place for the use of MR imaging in ovarian cancer.
format Text
id pubmed-2727977
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher e-Med
record_format MEDLINE/PubMed
spelling pubmed-27279772009-10-01 MR imaging in ovarian cancer Sohaib, S.A.A. Reznek, R.H. Cancer Imaging Article Magnetic resonance (MR) imaging is increasingly being used in patients with gynaecological disorders due to its high contrast resolution compared to computed tomography (CT) and ultrasound. In women presenting with an adnexal mass, ultrasound remains the primary imaging modality in the detection and characterisation of such lesions. However, in recent years overwhelming evidence has accumulated for the use of MR imaging in patients with indeterminate adnexal masses particularly in younger women and where disease markers are unhelpful. In staging ovarian cancer and for evaluating therapeutic response MR imaging is as accurate as CT but CT remains the imaging modality of choice because it is more widely available and quicker. This article reviews that evidence and outlines a place for the use of MR imaging in ovarian cancer. e-Med 2007-10-01 /pmc/articles/PMC2727977/ /pubmed/17921097 http://dx.doi.org/10.1102/1470-7330.2007.9046 Text en © 2007 International Cancer Imaging Society
spellingShingle Article
Sohaib, S.A.A.
Reznek, R.H.
MR imaging in ovarian cancer
title MR imaging in ovarian cancer
title_full MR imaging in ovarian cancer
title_fullStr MR imaging in ovarian cancer
title_full_unstemmed MR imaging in ovarian cancer
title_short MR imaging in ovarian cancer
title_sort mr imaging in ovarian cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2727977/
https://www.ncbi.nlm.nih.gov/pubmed/17921097
http://dx.doi.org/10.1102/1470-7330.2007.9046
work_keys_str_mv AT sohaibsaa mrimaginginovariancancer
AT reznekrh mrimaginginovariancancer